DNL Diurnal Group Plc

TIDMDNL

RNS Number : 2267X

Diurnal Group PLC

20 February 2017

20 February 2017

Diurnal Group plc

("Diurnal" or the "Company")

Appointment of Joint Broker

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, today announces the appointment of Panmure Gordon (UK) Limited to act as the Company's joint broker alongside Numis Securities Ltd, with immediate effect.

- Ends -

 
 For further information, please visit www.diurnal.co.uk 
  or contact: 
 
                                            +44 (0)20 3727 
 Diurnal Group plc                           1000 
 Martin Whitaker, CEO 
 Richard Bungay, CFO 
 
 Numis Securities Ltd (Nominated            +44 (0)20 7260 
  Adviser and Joint Broker)                  1000 
 Nominated Adviser: Michael Meade, 
  Freddie Barnfield, Paul Gillam 
 Corporate Broking: James Black 
 
 Panmure Gordon (UK) Limited (Joint         +44 (0) 20 
  Broker)                                    7886 2500 
 Corporate Finance: Freddy Crossley 
  / Duncan Monteith 
 Corporate Broking: Tom Salvesen 
 
                                            +44 (0)20 3727 
 FTI Consulting                              1000 
 Simon Conway 
 Victoria Foster Mitchell 
 

Notes to Editors

About Diurnal Group plc

Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

For further information about Diurnal, please visit www.diurnal.co.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPLLFVEFRIDLID

(END) Dow Jones Newswires

February 20, 2017 02:01 ET (07:01 GMT)

Diurnal (LSE:DNL)
Historical Stock Chart
From Apr 2024 to May 2024

Diurnal (LSE:DNL)
Historical Stock Chart
From May 2023 to May 2024